Numerous diseases have posed significant threats to public health, notably the global
pandemic of COVID-19, resulting in widespread devastation due to its high infectivity and …

Recent, outbreaks of new emergency zoonotic diseases have prompted an urgent need to
develop fast, accurate, and portable screening assays for pathogen infections …

A novel fluorescent biosensor was proposed for detecting the CaMV 35S promoter in
genetically modified organisms (GMOs). It was based on a proximity extension mediated …

Point-of-care (POC) HIV viral load (VL) tests are needed to enhance access to HIV VL
testing in low-and middle-income countries (LMICs) and to enable HIV VL self-testing at …

Quantitative nucleic acid amplification tests (qNAATs) are critical in treating infectious
diseases, such as in HIV viral load monitoring or SARS-CoV-2 testing, in which viral load …

Changes in the level of nucleic acids in blood may be correlated with some clinical disorders
like cancer, stroke, trauma and autoimmune diseases, and thus, nucleic acids can serve as …

For the 29.8 million people in the world living with HIV/AIDS and receiving antiretroviral
therapy, it is crucial to monitor their HIV viral loads. To this end, rapid and portable …

Intelligent point‐of‐care testing (iPOCT) is a rapidly advancing technology that combines
molecular detection and bio‐sensing techniques to achieve instant and accurate analysis …

Major advancements have been made in the past forty years to combat the HIV pandemic.
Viral load testing, a type of nucleic acid amplification test (NAAT), is a crucial tool in early …

BACKGROUND Sustainable living and One Health principles demand increased
surveillance of our environment to ensure a healthy environment, animals, and humans. The …